1,608
Views
27
CrossRef citations to date
0
Altmetric
Original Articles

Tamoxifen-loaded solid lipid nanoparticles-induced apoptosis in breast cancer cell lines

, &
Pages 161-174 | Received 30 Oct 2014, Accepted 29 Mar 2015, Published online: 05 May 2015

References

  • Fadok VA. Clearance: the last and often forgotten stage of apoptosis. J Mammary Gland Biol Neoplasia. 1999;4:203–211.
  • Messmer UK, Pfeilschifter J. New insights into the mechanism for clearance of apoptotic cells. Bio Essays. 2000;22:878–881.
  • Steel GG. The case against apoptosis. Acta Oncologica. 2001;40:968–975.
  • Salami S, Karami-Tehrani F. Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines. Clin Biochem. 2003;36:247–253.
  • Russo J, Russo IH. Mechanisms involved in carcinogenesis of the breast. In: Pasqualini JR, editor. Breast cancer. New York, NY: Taylor & Francis; 2002. p. 1–2.
  • Fontana G, Maniscalco L, Schillaci D, Cavallaro G. Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity. Drug Deliv. 2005;12:385–392.
  • Hashem FM, Nasr M, Khairy A. In vitro cytotoxicity and bioavailability of solid lipid nanoparticles containing tamoxifen citrate. Pharm Dev Technol. 2014;19(7):824–832.
  • Memisoglu-Bilensoy E, Vural I, Bochot A, Renoir JM, Ducheneb D, AtillaHincal A. Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity. J Controlled Release. 2005;104:489–496.
  • Chawla JS, Amiji MM. Cellular uptake and concentrations of tamoxifen upon administration in poly(-caprolactone) nanoparticles. Am Assoc Pharm Scientists J. 2003;5:28–34.
  • Abbasalipourkabir R, Salehzadeh A, Rasedee Abdullah. Antitumor activity of tamoxifen loaded solid lipid nanoparticles on induced mammary tumor gland in Sprague-Dawley rats. Afr J Biotech. 2010;9(43):7337–7345.
  • Tran TH, Ramasamy T, Cho HJ, Kim YI, Poudel BK, Choi HG, Yong CS, Kim JO. Formulation and optimization of raloxifen-loaded solid lipid nanoparticles to enhance oral bioavailability. J Nanosci Nanotechnol. 2014;14(7):4820–4831.
  • Crissman HA, Steinkamp JA. Rapid simultaneous measurement of DNA, protein and cell volume in single cells from large mammalian cell populations. J Cell Biol. 1973;59:766–771.
  • Krishan A. Rapid flow cytofluorometric analysis of cell cycle by propidium iodide staining. J Cell Biol. 1975;6:188–193.
  • Hishikava K, Nakaki T, Fujii T. Transformation growth factor-b1 induces apoptosis via connective tissue growth factor in human aortic smooth muscle cells. Eur J Pharmacol. 1999;385:287–290.
  • Gelman EP. Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: new tricks for an old dog? J Natl Cancer Inst. 1996;88:224–226.
  • Serpe L, Laurora S, Pizzimenti S, Ugazio E, Ponti R, Canaparo R, Briatore F, Barrera G, Gasco MR, Bernengo MG, Eandi M, Zara GP. Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells. Anti-Cancer Drug. 2004;15:525–536.
  • Yuan H, Miao J, Du YZ, You J, Hu FQ, Su Z. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm. 2008;348:137–145.
  • Schubert MA, Müller-Goymann CC. Characterization of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm. 2005;61:77–86.
  • Schöler N, Zimmermann E, Katzfey U, Hahn H, Müller RH, Liesenfeld O. Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages. Int J Pharm. 2000;196:235–239.
  • Schöler N, Olbrich C, Tabatt K, Müller RH, Hahn H, Liesenfeld O. Surfactant but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int J Pharm. 2001;221:57–67.
  • Müller RH, Maassen S, Schwarts C, Mehnert W. Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes. J Control Release. 1997;47:261–269.
  • Yu T, Lee J, Lee YG, Byeon SE, Kim MH, Sohn EH, Lee YJ, Lee SG, Youl J. In vitro and in vivo anti-inflammatory effects of ethanol extract from Acer tegmentosum. J Ethnopharmacol. 2010;128(1):139–147.
  • Latt SA, Stetten G. Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis. J Histochem Cytochem. 1976;24:24–33.
  • Green DR, Reed JC. Mitochondria and Apoptosis. Science. 1998;281:1309–1312.
  • Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770–776.
  • Tavassoli M, Soltaninia J, Rudnicka J, Mashanyare D, Johnson N, Gäken J. Tamoxifen inhibits the growth of head and neck cancer cells and sensitizes these cells to cisplatin induced-apoptosis: role of TGF-b1. Carcinogenesis. 2002;23:1569–1575.
  • Clemons M, Danson S, Howell A. Tamoxifen (nolvadex): a review. Cancer Treat Rev. 2002;28:165–180.
  • Budtz PE. Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen. Cell Prolif. 1999;32:289–302.
  • Perry RR, Kang Y, Greaves B. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Ann Surg Oncol. 1995;2:238–245.
  • Martin G, Melito G, Rivera E. Effect of tamoxifen on intraperitoneal N-nitroso-N-methylurea induced tumors. Cancer Lett. 1996;100:227–234.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.